Edema Mechanisms in the Patient with Heart Failure and Treatment Options

Heart Failure Clinics

Volumn 4, Issue 4, 2008, Pages 511-518

  Sica, Domenic A ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ALDOSTERONE ANTAGONIST; AMILORIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUMETANIDE; CHLORTALIDONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EPLERENONE; FUROSEMIDE; HYDROCHLOROTHIAZIDE; LOOP DIURETIC AGENT; METOLAZONE; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT; TRIAMTERENE;

ADRENERGIC SYSTEM; EDEMA; HEART FAILURE; KIDNEY FUNCTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SODIUM INTAKE;

DIURETICS; EDEMA; HEART FAILURE; HUMANS; RENIN-ANGIOTENSIN SYSTEM; RISK FACTORS; SYMPATHETIC NERVOUS SYSTEM;

EID: 50049084611     PISSN: 15517136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hfc.2008.04.002     Document Type: Review

References (51)

1. Schrier R.W., and Abraham W.T. Hormones and hemodynamics in heart failure. N Engl J Med 341 (1999) 577-585
2. Damman K., Navis G., Voors A.A., et al. Worsening renal function and prognosis in heart failure: systematic review and meta-analysis. J Card Fail 13 (2007) 599-608
3. Rea M.E., and Dunlap M.E. Renal hemodynamics in heart failure: implications for treatment. Curr Opin Nephrol Hypertens 17 (2008) 87-92
4. Sica D.A., and Gehr T.W.B. Diuretic combinations in refractory edema states: pharmacokinetic/pharmacodynamic relationships. Clin Pharmacokinet 30 (1996) 229-249
5. Meyers B.D., Deen W.M., and Brenner B.M. Effects of norepinephrine and angiotensin II on the determinants of glomerular ultrafiltration and proximal tubule fluid reabsorption in the rat. Circ Res 37 (1983) 101-110
6. Schoolwerth A., Sica D.A., Ballermann B.J., et al. Renal considerations in angiotensin converting enzyme inhibitor therapy. Circulation 104 (2001) 1985-1991
7. Kaye D., and Esler M. Sympathetic neuronal regulation of the heart in aging and heart failure. Cardiovasc Res 66 (2005) 256-264
8. Watson A.M., Hood S.G., and May C.N. Mechanisms of sympathetic activation in heart failure. Clin Exp Pharmacol Physiol 33 (2006) 1269-1274
9. DiBona G.F. Peripheral and central interactions between the renin-angiotensin system and the renal sympathetic nerves in control of renal function. Ann N Y Acad Sci 940 (2001) 395-406
10. Chen H.H., and Schrier R.W. Pathophysiology of volume overload in acute heart failure syndromes. Am J Med 119 12 Suppl 1 (2006) S11-S16
11. 1-beta-blockade in congestive heart failure. Scand J Clin Lab Invest 62 (2002) 97-104
12. Dupont A.G. Effects of carvedilol on renal function. Eur J Clin Pharmacol 38 Suppl 2 (1990) S96-S100
13. Sica D.A. Sodium and water retention in heart failure and diuretic therapy: basic mechanisms. Cleve Clin J Med 73 Suppl 2 (2006) 82-87
14. Cooper H.A., Dries D.L., Davis C.E., et al. Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction. Circulation 100 (1999) 1311-1315
15. Neuberg G.W., Miller A.B., O'Connor C.M., et al. Diuretic resistance predicts mortality in patients with advanced heart failure. Am Heart J 144 (2002) 31-38
16. Gomolin I.H., and Chapron D.J. Elucidating the relationship between acetazolamide plasma protein binding and renal clearance using an albumin infusion. J Clin Pharmacol 32 (1992) 1028-1032
17. Skøtt P., Hommel E., Bruun N.E., et al. Effects of acetazolamide on kidney function in type 1 (insulin-dependent) diabetic patients with diabetic nephropathy. Diabetologia 31 (1988) 806-810
18. Mazur J.E., Devlin J.W., Peters M.J., et al. Single versus multiple doses of acetazolamide for metabolic alkalosis in critically ill medical patients: a randomized, double-blind trial. Crit Care Med 27 (1999) 1257-1261
19. Leary W.P., and Reyes A.J. Diuretic-induced magnesium losses. Drugs 28 Suppl 1 (1984) 182-187
20. Beerman B., and Groschinsky-Grind M. Pharmacokinetics of hydrochlorothiazide in patients with congestive heart failure. Br J Clin Pharmacol 7 (1979) 579-583
21. Knauf H., and Mutschler E. Diuretic effectiveness of hydrochlorothiazide and furosemide alone and in combination in chronic renal failure. J Cardiovasc Pharmacol 26 (1995) 394-400
22. Dormans T.P., and Gerlag P.G. Combination of high-dose furosemide and hydrochlorothiazide in the treatment of refractory congestive heart failure. Eur Heart J 17 (1996) 1867-1874
23. Sica D.A. Pharmacotherapy in congestive heart failure: metolazone and its role in edema management. Congest Heart Fail 9 (2003) 100-105
24. Shankar S.S., and Brater D.C. Loop diuretics: from the Na-K-2Cl transporter to clinical use. Am J Physiol Renal Physiol 284 (2003) F11-F21
25. Liguori A., Casini A., Di Loreto M., et al. Loop diuretics enhance the secretion of prostacyclin in vitro, in healthy persons, and in patients with chronic heart failure. Eur J Clin Pharmacol 55 (1999) 117-124
26. Sjöström P.A., Kron B.G., and Odlind B.G. Changes in renal clearance of furosemide due to changes in renal blood flow and plasma albumin concentration. Eur J Clin Pharmacol 45 (1993) 135-139
27. Dixey J.J., Noormohamed F.H., Pawa J.S., et al. The influence of nonsteroidal anti-inflammatory drugs and probenecid on the renal response to and kinetics of piretanide in man. Clin Pharmacol Ther 44 (1988) 531-539
28. Brater D.C. Diuretic therapy. N Engl J Med 339 (1998) 387-395
29. Brater D.C. Pharmacokinetics of loop diuretics in congestive heart failure. Br Heart J 72 2 Suppl (1994) S40-S43
30. Murphy C.A., and Dargie H.J. Drug-induced cardiovascular disorders. Drug Saf 30 (2007) 783-804
31. Murray M.D., Haag K.M., Black P.K., et al. Variable furosemide absorption and poor predictability of response in elderly patients. Pharmacotherapy 17 (1997) 98-106
32. Vargo D.L., Kramer W.G., Black P.K., et al. Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure. Clin Pharmacol Ther 57 (1995) 601-609
33. Murray M.D., Deer M.M., Ferguson J.A., et al. Open-label randomized trial of torsemide compared with furosemide therapy for patients with heart failure. Am J Med 111 (2001) 513-520
34. Sica D.A., and Gehr T.W. Diuretic use in stage 5 chronic kidney disease and end-stage renal disease. Curr Opin Nephrol Hypertens 12 (2003) 483-490
35. Gardiner P., Schrode K., Quinlan D., et al. Spironolactone metabolism: steady-state serum levels of the sulfur-containing metabolites. J Clin Pharmacol 29 (1989) 342-347
36. Pitt B., Remme W., Zannad F., et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348 (2003) 1309-1321
37. Cheitlin M.D., Byrd R., Benowitz N., et al. Amiloride improves hemodynamics in patients with chronic congestive heart failure treated with chronic digoxin and diuretics. Cardiovasc Drugs Ther 5 (1991) 719-725
38. Kohvakka A. Maintenance of potassium balance during long-term diuretic therapy in chronic heart failure patients with thiazide-induced hypokalemia: comparison of potassium supplementation with potassium chloride and potassium-sparing agents, amiloride and triamterene. Int J Clin Pharmacol Ther Toxicol 26 (1988) 273-277
39. Favre L., Glasson P., and Vallotton M.B. Reversible acute renal failure from combined triamterene and indomethacin: a study in healthy subjects. Ann Intern Med 96 (1982) 317-320
40. Vasko M.R., Brown-Cartwright D., Knochel J.P., et al. Furosemide absorption altered in decompensated congestive heart failure. Ann Intern Med 102 (1985) 314-318
41. Ellison D.H. Diuretic drugs and the treatment of edema: from clinic to bench and back again. Am J Kidney Dis 23 (1994) 623-643
42. Kelly R.A., Wilcox C.S., Mitch W.E., et al. Response of the kidney to furosemide. II. Effect of captopril on sodium balance. Kidney Int 24 (1983) 233-239
43. + and BP homeostasis in man during furosemide: effects of prazosin and captopril. Kidney Int 31 (1987) 135-141
44. Almeshari K., Ahlstom N.G., Capraro F.E., et al. A volume-independent component to post-diuretic sodium retention in man. J Am Soc Nephrol 3 (1993) 1878-1883
45. Ellison D.H., Velazquez H., and Wright F.S. Adaptation of the distal convoluted tubule of the rat. Structural and functional effects of dietary salt intake and chronic diuretic infusion. J Clin Invest 83 (1989) 113-126
46. Wilcox C.S., Mitch W.E., Kelly R.A., et al. Response of the kidney to furosemide. I. Effects of salt intake and renal compensation. J Lab Clin Med 102 (1983) 450-458
47. Abdallah J.G., Schrier R.W., Edelstein C., et al. Loop diuretic infusion increases thiazide-sensitive Na(+)/Cl(-)-cotransporter abundance: role of aldosterone. J Am Soc Nephrol 12 (2001) 1335-1341
48. Loon N.R., Wilcox C.S., and Unwin R.J. Mechanism of impaired natriuretic response to furosemide during prolonged therapy. Kidney Int 36 (1989) 682-689
49. Ellison D.H. The physiologic basis of diuretic synergism: its role in treating diuretic resistance. Ann Intern Med 114 (1991) 886-894
50. Salvador D.R., Rey N.R., Ramos G.C., et al. Continuous infusion versus bolus injection of loop diuretics in congestive heart failure. Cochrane Database Syst Rev 1 (2004) CD003178
51. Dikshit K., Vyden J.K., Forrester J.S., et al. Renal and extrarenal hemodynamic effects of furosemide in congestive heart failure after acute myocardial infarction. N Engl J Med 288 (1973) 1087-1090